NO20016389L - Fremgangsmåte for fremstilling av substituerte cyklopentanderivater og nye krystallinske strukturer derav - Google Patents

Fremgangsmåte for fremstilling av substituerte cyklopentanderivater og nye krystallinske strukturer derav

Info

Publication number
NO20016389L
NO20016389L NO20016389A NO20016389A NO20016389L NO 20016389 L NO20016389 L NO 20016389L NO 20016389 A NO20016389 A NO 20016389A NO 20016389 A NO20016389 A NO 20016389A NO 20016389 L NO20016389 L NO 20016389L
Authority
NO
Norway
Prior art keywords
preparation
crystalline structures
substituted cyclopentane
new crystalline
cyclopentane derivatives
Prior art date
Application number
NO20016389A
Other languages
English (en)
Other versions
NO20016389D0 (no
Inventor
Ahmed F Abdel-Magid
Hans-Ulrich Bichsel
Daniel J Korey
Gunther G Laufer
Erja A Lehto
Sebastiano Mattei
Max Rey
Thomas W Schultz
Cynthia Maryanoff
Original Assignee
Biocryst Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocryst Pharm Inc filed Critical Biocryst Pharm Inc
Publication of NO20016389D0 publication Critical patent/NO20016389D0/no
Publication of NO20016389L publication Critical patent/NO20016389L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/16—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Fremstilling av fremgangsmåten av substituerte cyklopentan derivater representert ved formel (I) der R1, R2, R3, R4, X og Y kan ha diverse betydninger samt farmasøytiske akseptable salter derav. Det beskrives videre en fremgangsmåte for å rense forbindelsene med formel (la) og nye krystallinske former av forbindelsen med formel (la).
NO20016389A 1999-06-28 2001-12-27 Fremgangsmåte for fremstilling av substituerte cyklopentanderivater og nye krystallinske strukturer derav NO20016389L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14130199P 1999-06-28 1999-06-28
PCT/US2000/016013 WO2001000571A1 (en) 1999-06-28 2000-06-09 Process for preparing substituted cyclopentane derivatives and novel crystalline structures thereof

Publications (2)

Publication Number Publication Date
NO20016389D0 NO20016389D0 (no) 2001-12-27
NO20016389L true NO20016389L (no) 2002-02-21

Family

ID=22495095

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20016389A NO20016389L (no) 1999-06-28 2001-12-27 Fremgangsmåte for fremstilling av substituerte cyklopentanderivater og nye krystallinske strukturer derav

Country Status (16)

Country Link
US (1) US6576786B2 (no)
EP (1) EP1214294A1 (no)
JP (2) JP4262920B2 (no)
KR (1) KR20020022727A (no)
CN (1) CN1367776A (no)
AR (1) AR024494A1 (no)
AU (1) AU5732700A (no)
BR (1) BR0011902A (no)
CA (1) CA2377240A1 (no)
CZ (1) CZ20014657A3 (no)
HU (1) HUP0202097A2 (no)
IL (1) IL147244A0 (no)
NO (1) NO20016389L (no)
PL (1) PL213231B1 (no)
SK (1) SK19042001A3 (no)
WO (1) WO2001000571A1 (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0011902A (pt) * 1999-06-28 2002-03-19 Biocryst Pharm Inc Compostos derivados de ciclopentano substituìdo, respectivos processos de preparação e formas cristalinas
WO2001062242A1 (en) * 2000-02-24 2001-08-30 Biocryst Pharmaceuticals, Inc. Prodrugs of substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors
US7405336B2 (en) * 2004-10-18 2008-07-29 Fina Technology, Inc. Promoters for controlling acidity and pore size of zeolite catalysts for use in alkylation
WO2007087056A2 (en) * 2006-01-13 2007-08-02 Scolr Pharma, Inc. Peramivir derivative for oral administration
US20070203241A1 (en) * 2006-02-13 2007-08-30 Babu Yarlagadda S Antiviral treatments
US20070244193A1 (en) * 2006-04-12 2007-10-18 Babu Yarlagadda S Intramuscular antiviral treatments
JP2008162935A (ja) * 2006-12-28 2008-07-17 Daicel Chem Ind Ltd アミド又はラクタムの製造法
CN101367750B (zh) 2007-08-14 2012-05-23 中国人民解放军军事医学科学院毒物药物研究所 (1s,2s,3s,4r)-3-[(1s)-1-乙酰氨-2-乙基-丁基]-4-胍基-2-羟基-环戊基-1-羧酸水合物及其医药用途
CN102584637B (zh) * 2011-01-17 2014-07-09 天津药物研究院 帕拉米韦水合物晶体、制备方法、药用组合物及其用途
CN102757365B (zh) * 2011-04-29 2013-10-30 上海泓博智源医药技术有限公司 一种制备帕拉米韦关键中间体的方法
CN102372657B (zh) * 2011-11-14 2014-04-09 暨南大学 一种抗流感及禽流感病毒药物帕拉米韦的合成方法
CN102863359B (zh) * 2012-05-16 2014-05-07 常州制药厂有限公司 一种抗流感药物的合成方法
CN105198827A (zh) * 2015-04-13 2015-12-30 广州南新制药有限公司 一种帕拉米韦中间体的合成方法
CN108997171B (zh) * 2018-06-21 2020-11-27 苏州正济医药研究有限公司 一种3+2关环的合成方法
CN112250601B (zh) * 2020-09-08 2022-09-27 天津应天成科技有限公司 安全无毒去除帕拉米韦三水合物中间体m9中镍离子杂质的方法
CN114181117B (zh) * 2020-09-15 2023-05-05 南京正济医药研究有限公司 一种帕拉米韦中间体的制备方法
CN116425659B (zh) * 2023-03-02 2023-11-03 浙江康聚药业有限公司 一种合成帕拉米韦的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0100142A3 (en) * 1997-12-17 2002-01-28 Biocryst Pharmaceuticals Inc B Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors
BR0011902A (pt) * 1999-06-28 2002-03-19 Biocryst Pharm Inc Compostos derivados de ciclopentano substituìdo, respectivos processos de preparação e formas cristalinas

Also Published As

Publication number Publication date
AR024494A1 (es) 2002-10-02
JP2009073859A (ja) 2009-04-09
SK19042001A3 (sk) 2002-04-04
NO20016389D0 (no) 2001-12-27
BR0011902A (pt) 2002-03-19
US6576786B2 (en) 2003-06-10
IL147244A0 (en) 2002-08-14
AU5732700A (en) 2001-01-31
JP4262920B2 (ja) 2009-05-13
PL352992A1 (en) 2003-09-22
HUP0202097A2 (en) 2002-10-28
US20020061930A1 (en) 2002-05-23
CA2377240A1 (en) 2001-01-04
WO2001000571A1 (en) 2001-01-04
PL213231B1 (pl) 2013-01-31
CN1367776A (zh) 2002-09-04
JP4597237B2 (ja) 2010-12-15
EP1214294A1 (en) 2002-06-19
JP2003503384A (ja) 2003-01-28
KR20020022727A (ko) 2002-03-27
CZ20014657A3 (cs) 2002-10-16

Similar Documents

Publication Publication Date Title
NO20016389L (no) Fremgangsmåte for fremstilling av substituerte cyklopentanderivater og nye krystallinske strukturer derav
EP1103552A4 (en) BENZOTHIEPINE DERIVATIVES, METHOD FOR THEIR PRODUCTION AND THEIR USE
MXPA04006322A (es) Derivados de 6-fluorobiciclo[3.1.0]hexano.
NO20071547L (no) Nye krystallinske og amorfe former av en triazolo(4,5-D)pyrimidinforbindelse
WO2002100833A1 (fr) Inhibiteurs de rho kinase
CA2445306A1 (en) Process for preparing 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
WO2000010965A3 (en) Quaternary ammonium salts and their use as anti-hiv agents
YU70901A (sh) Derivati 1,4-benzotiazepin-1,1 dioksida zamenjeni radikalima šećera, postupak za njihovu proizvodnju, lekovi koji sadrže ova jedinjenja i njihova primena
CA2160444A1 (en) Aroyl-piperdine derivatives
CA2328780A1 (en) Dihydropyrimidines
WO2005058884A3 (en) Cyclopropane compounds and pharmaceutical use thereof
CA2334775A1 (en) Benzo(b)thiepine-1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
CA2398620A1 (en) Pyrazine derivatives, pharmaceutical compositions containing them, and intermediates therefor
NO306780B1 (no) Carbapenem-antibiotika
EP1642880A4 (en) PROTEIN INHIBITOR OF THE HSP90 FAMILY
NO933837L (no) 4-aryl-3-(heteroarylureido)kinolin-derivater
WO2000018722A3 (es) Nuevos derivados de la 6-(4-fenilbutoxi)hexilamina y procedimiento para la obtencion de salmeterol
CA2318694A1 (en) Antivirals
WO2002059089A3 (en) Process for the preparation of heterocyclic indene analogs
AR019197A1 (es) COMPUESTOS DERIVADOS DE PIPERIDINA ANTIHISTAMINICOS, COMPUESTOS INTERMEDIOS, PROCEDIMIENTO DE PREPARACIoN DE DERIVADOS DE PIPERIDINA Y PROCEDIMIENTOS DE PREPARACIoN DE INTERMEDIARIOS.
CA2163253A1 (en) N-p-halobenzoylmethyl derivatives of 4-(p-fluorophenyl)-3-¬¬3,4-methylenedioxy)phenoxy|methyl|piperidine
WO2002060878A1 (en) Benzimidazolidinone derivatives
EP1270569A4 (en) SUBSTITUTED TRYPTOPHAN DERIVATIVES
CA2427812A1 (en) Novel .beta.-lactam compounds and process for producing the same
NO913644L (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application